Status:
UNKNOWN
The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients
Lead Sponsor:
Camillians Saint Mary's Hospital Luodong
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Background: Patients with decreased kidney function are in the positive acid balance due to insufficient renal acid excretion. To correct the varying degrees of metabolic acidosis in these HD patient...
Eligibility Criteria
Inclusion
- adult uremic patients who received hemodialysis thrice weekly
Exclusion
- Hospitalized patients
- Patients newly initiated on HD (\<6 months)
- Patients with HD access problems
- Patients recently discharged from the hospital (within one month).
- Patients on chemotherapy for cancer.
- Patients with a kidney transplant.
- Patients on steroids or other immunosuppressive therapy.
- Patients with recent surgery (within one month)
- Patients with an active bacterial infection.
- Patients with decompensated cirrhosis.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04070690
Start Date
August 1 2019
End Date
February 1 2020
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Mary's Hospital Luodong
Yilan, Taiwan, 265